|
English
|
正體中文
|
简体中文
|
总笔数 :2856704
|
|
造访人次 :
53644415
在线人数 :
2145
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"yu h j"的相关文件
显示项目 171-180 / 421 (共43页)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; Tsai C.-L.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:56Z |
CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1�\-induced twist expression
|
Chen P.-C.;Tai H.-C.;Lin T.-H.;Wang S.-W.;Lin C.-Y.;Chao C.-C.;Yu H.-J.;Yu-Chieh Tsai;Lai Y.-W.;Lin C.-W.;Tang C.-H.; Chen P.-C.; Tai H.-C.; Lin T.-H.; Wang S.-W.; Lin C.-Y.; Chao C.-C.; Yu H.-J.; YU-CHIEH TSAI; Lai Y.-W.; Lin C.-W.; Tang C.-H. |
| 臺大學術典藏 |
2021-03-03T03:01:24Z |
Importance of urodynamic study before radical hysterectomy for cervical cancer
|
Ho-Hsiung Lin;Yu H.-J.;Sheu B.-C.;Huang S.-C.; HO-HSIUNG LIN; Yu H.-J.; Sheu B.-C.; Huang S.-C. |
| 臺大學術典藏 |
2021-03-03T03:01:12Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Ho-Hsiung Lin;Liu S.-P.;Huang K.-H.;Yu H.-J.; Ho C.-H.; Chang T.-C.; HO-HSIUNG LIN; Liu S.-P.; Huang K.-H.; Yu H.-J. |
| 臺大學術典藏 |
2021-03-03T03:01:11Z |
Comparison of overall sexual function, sexual intercourse/activity, sexual satisfaction, and sexual desire during the three trimesters of pregnancy and assessment of their determinants
|
Chang S.-R.;Chen K.-H.;Ho-Hsiung Lin;Yu H.-J.; Chang S.-R.; Chen K.-H.; HO-HSIUNG LIN; Yu H.-J. |
| 臺大學術典藏 |
2021-03-03T03:01:09Z |
Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome
|
Hsiao S.-M.;Chang T.-C.;Wu W.-Y.;Chen C.-H.;Yu H.-J.;Ho-Hsiung Lin; Hsiao S.-M.; Chang T.-C.; Wu W.-Y.; Chen C.-H.; Yu H.-J.; HO-HSIUNG LIN |
| 臺大學術典藏 |
2021-03-03T03:00:57Z |
Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010
|
Kuo H.-C.; HO-HSIUNG LIN; Yu H.-J.; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team |
| 臺大學術典藏 |
2021-03-03T03:00:57Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo H.-C.; HO-HSIUNG LIN; Yu H.-J.; Cheng C.-L.; Hung M.-J.; Lin A.T.L. |
| 臺大學術典藏 |
2021-02-08T07:23:56Z |
Secular trend and age-period-cohort analysis of prostate cancer mortality in Taiwan
|
Chang C.-K.;Yu H.-J.;Kin-Wei Chan;Lai M.-K.; Chang C.-K.; Yu H.-J.; KIN-WEI CHAN; Lai M.-K. |
| 臺大學術典藏 |
2021-02-08T07:23:55Z |
Factors related to delayed treatment and posttreatment symptom severity in Taiwanese patients with benign prostatic hyperplasia
|
Chang C.-K.;Yu H.-J.;Kin-Wei Chan;Chie W.-C.;Chen J.;Chen Y.-T.;Lai M.-K.; Chang C.-K.; Yu H.-J.; KIN-WEI CHAN; Chie W.-C.; Chen J.; Chen Y.-T.; Lai M.-K. |
显示项目 171-180 / 421 (共43页)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
每页显示[10|25|50]项目
|
